Literature DB >> 19432560

The carbohydrate-binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: implications for galectin-glycan interactions at the cell surface.

Michelle C Miller1, Irina V Nesmelova, David Platt, Anatole Klyosov, Kevin H Mayo.   

Abstract

gal-1 (galectin-1) mediates cell-cell and cell-extracellular matrix adhesion, essentially by interacting with beta-galactoside-containing glycans of cell-surface glycoconjugates. Although most structural studies with gal-1 have investigated its binding to simple carbohydrates, in particular lactose and N-acetyl-lactosamine, this view is limited, because gal-1 functions at the cell surface by interacting with more complex glycans that are heterogeneous in size and composition. In the present study we used NMR spectroscopy to investigate the interaction of human gal-1 with a large (120 kDa) complex glycan, GRG (galactorhamnogalacturonate glycan), that contains non-randomly distributed mostly terminal beta(1-->4)-linked galactose side chains. We used 15N-1H-HSQC (heteronuclear single quantum coherence) NMR experiments with 15N-enriched gal-1 to identify the GRG-binding region on gal-1 and found that this region covers a large surface area on gal-1 that includes the quintessential lactose-binding site and runs from that site through a broad valley or cleft towards the dimer interface. HSQC and pulsed-field-gradient NMR diffusion experiments also show that gal-1 binds GRG with a gal-1:GRG stoichiometry of about 5:1 (or 6:1) and with average macroscopic and microscopic equilibrium dissociation constants (Kd) of 8 x 10(-6) M and 40 x 10(-6) M (or 48 x 10(-6) M) respectively, indicating stronger binding than to lactose (Kd=520 x 10(-6) M). Although gal-1 may bind GRG in various ways, the glycan can be competed for by lactose, suggesting that there is one major mode of interaction. Furthermore, even though terminal motifs on GRG are Gal-beta(1-->4)-Gal rather than the traditional Gal-beta(1-->4)-Glc/GlcNAc (where GlcNAc is N-acetylglucosamine), we show that the disaccharide Gal-beta(1-->4)-Gal can bind gal-1 at the lactose-binding domain. In addition, gal-1 binding to GRG disrupts inter-glycan interactions and decreases glycan-mediated solution viscosity, a glycan decongestion effect that may help explain why gal-1 promotes membrane fluidity and lateral diffusion of glycoconjugates within cell membranes. Overall, our results provide an insight into the function of galectin in situ and have potential significant biological consequences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19432560      PMCID: PMC2708933          DOI: 10.1042/BJ20090265

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

Review 1.  Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions.

Authors:  C Fred Brewer; M Carrie Miceli; Linda G Baum
Journal:  Curr Opin Struct Biol       Date:  2002-10       Impact factor: 6.809

2.  Structure and functional analysis of the fungal galectin CGL2.

Authors:  Piers J Walser; Peter W Haebel; Markus Künzler; David Sargent; Ursula Kües; Markus Aebi; Nenad Ban
Journal:  Structure       Date:  2004-04       Impact factor: 5.006

Review 3.  Cell surface biology mediated by low affinity multivalent protein-glycan interactions.

Authors:  Brian E Collins; James C Paulson
Journal:  Curr Opin Chem Biol       Date:  2004-12       Impact factor: 8.822

4.  Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.

Authors:  Pratima Nangia-Makker; Victor Hogan; Yuichiro Honjo; Sara Baccarini; Larry Tait; Robert Bresalier; Avraham Raz
Journal:  J Natl Cancer Inst       Date:  2002-12-18       Impact factor: 13.506

5.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

6.  Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1.

Authors:  K E Pace; C Lee; P L Stewart; L G Baum
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

7.  A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.

Authors:  Dharminder Chauhan; Guilan Li; Klaus Podar; Teru Hideshima; Paola Neri; Deli He; Nicholas Mitsiades; Paul Richardson; Yan Chang; Joanne Schindler; Bradley Carver; Kenneth C Anderson
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

8.  Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis.

Authors:  Emily A Partridge; Christine Le Roy; Gianni M Di Guglielmo; Judy Pawling; Pam Cheung; Maria Granovsky; Ivan R Nabi; Jeffrey L Wrana; James W Dennis
Journal:  Science       Date:  2004-10-01       Impact factor: 47.728

9.  Using pulse field gradient NMR diffusion measurements to define molecular size distributions in glycan preparations.

Authors:  Michelle C Miller; Anatole Klyosov; David Platt; Kevin H Mayo
Journal:  Carbohydr Res       Date:  2009-04-17       Impact factor: 2.104

10.  Desulfated galactosaminoglycans are potential ligands for galectins: evidence from frontal affinity chromatography.

Authors:  Jun Iwaki; Toshikazu Minamisawa; Hiroaki Tateno; Junko Kominami; Kiyoshi Suzuki; Nozomu Nishi; Takanori Nakamura; Jun Hirabayashi
Journal:  Biochem Biophys Res Commun       Date:  2008-06-13       Impact factor: 3.575

View more
  19 in total

Review 1.  Engineering galectin-glycan interactions for immunotherapy and immunomodulation.

Authors:  Shaheen A Farhadi; Gregory A Hudalla
Journal:  Exp Biol Med (Maywood)       Date:  2016-05

2.  Microarray Analysis of Oligosaccharide-Mediated Multivalent Carbohydrate-Protein Interactions and Their Heterogeneity.

Authors:  Madhuri Gade; Catherine Alex; Shani Leviatan Ben-Arye; João T Monteiro; Sharon Yehuda; Bernd Lepenies; Vered Padler-Karavani; Raghavendra Kikkeri
Journal:  Chembiochem       Date:  2018-03-25       Impact factor: 3.164

3.  Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1.

Authors:  Ruud P M Dings; Nigam Kumar; Michelle C Miller; Melissa Loren; Huzaifa Rangwala; Thomas R Hoye; Kevin H Mayo
Journal:  J Pharmacol Exp Ther       Date:  2012-12-11       Impact factor: 4.030

4.  Structural aspects of binding of α-linked digalactosides to human galectin-1.

Authors:  Michelle C Miller; João P Ribeiro; Virginia Roldós; Sonsoles Martín-Santamaría; F Javier Cañada; Irina A Nesmelova; Sabine André; Mabel Pang; Anatole A Klyosov; Linda G Baum; Jesús Jiménez-Barbero; Hans-Joachim Gabius; Kevin H Mayo
Journal:  Glycobiology       Date:  2011-06-28       Impact factor: 4.313

5.  Structural features for α-galactomannan binding to galectin-1.

Authors:  Michelle C Miller; Anatole A Klyosov; Kevin H Mayo
Journal:  Glycobiology       Date:  2011-12-07       Impact factor: 4.313

6.  Disaccharide binding to galectin-1: free energy calculations and molecular recognition mechanism.

Authors:  Ignacia Echeverria; L Mario Amzel
Journal:  Biophys J       Date:  2011-05-04       Impact factor: 4.033

Review 7.  When galectins recognize glycans: from biochemistry to physiology and back again.

Authors:  Santiago Di Lella; Victoria Sundblad; Juan P Cerliani; Carlos M Guardia; Dario A Estrin; Gerardo R Vasta; Gabriel A Rabinovich
Journal:  Biochemistry       Date:  2011-08-26       Impact factor: 3.162

8.  Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain.

Authors:  Michelle C Miller; Hans Ippel; Dennis Suylen; Anatole A Klyosov; Peter G Traber; Tilman Hackeng; Kevin H Mayo
Journal:  Glycobiology       Date:  2016-01       Impact factor: 4.313

9.  Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerization.

Authors:  Michelle C Miller; Y Zheng; Jingmin Yan; Yifa Zhou; Guihua Tai; Kevin H Mayo
Journal:  Glycobiology       Date:  2017-11-01       Impact factor: 4.313

10.  The alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain.

Authors:  Michelle C Miller; Anatole Klyosov; Kevin H Mayo
Journal:  Glycobiology       Date:  2009-06-18       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.